triethylenemelamine has been researched along with Chronic Disease in 4 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
Excerpt | Relevance | Reference |
---|---|---|
"Urethane is the best treatment available for multiple myeloma." | 1.23 | New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MARLOW, AA | 1 |
BARTLETT, GR | 1 |
NEUMANN, C | 1 |
HAEHNER, E | 1 |
HEINEN, W | 1 |
LOOSEN, H | 1 |
SCHMIDT, H | 1 |
MEZA ARRAU, C | 1 |
NIJAMKIN, A | 1 |
4 other studies available for triethylenemelamine and Chronic Disease
Article | Year |
---|---|
New therapy for leukemia, polycythemia, and lymphoma.
Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple | 1953 |
[Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
Topics: Chronic Disease; Cytostatic Agents; Hodgkin Disease; Leukemia; Sarcoidosis; Triethylenemelamine | 1952 |
[Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
Topics: Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Triethylenemelamine | 1954 |
[Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias].
Topics: Chronic Disease; Hodgkin Disease; Leukemia; Lymphoma; Triethylenemelamine | 1955 |